PDS Biotech hosts virtual KOL event on PDS0301 in advanced colorectal cancer with liver metastases
PDSB•PDS Biotech will host a virtual KOL event on Oct. 15, 2026, at 8:00 a.m. ET, focused on Phase 2 outcomes for PDS0301 in advanced liver-associated cancers, including metastatic colorectal cancer.
1. Event details
The discussion will cover second- and third-line unresectable MSS or pMMR colorectal liver metastases, a setting where immunotherapy has largely underperformed.
